Oral-ibuprofen-induced acute renal failure in a preterm infant

Pediatric Nephrology

Volumn 23, Issue 9, 2008, Pages 1565-1567

  Erdeve, Omer ^a,b   Sarici, S Umit ^a   Sari, Erkan ^a   Gok, Faysal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Ibuprofen; Oral; Patent ductus arteriosus; Renal failure; Side effect

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; DOPAMINE; IBUPROFEN;

ACUTE KIDNEY FAILURE; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; ECHOCARDIOGRAPHY; FEMALE; FLUID THERAPY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION TEST; LUNG EDEMA; NEWBORN; NEWBORN INTENSIVE CARE; OLIGURIA; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY FAILURE, ACUTE;

EID: 47749119951     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0835-9     Document Type: Article

References (18)

1. Shah SS, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 1:CD004213
2. Giniger RP, Buffat C, Millet V, Simeoni U (2007) Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants. J Maternal Fetal Neonatal Med 20:275-283
3. Tiker F, Yildirim SF (2007) Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatr 44:54-55
4. Heyman E, Morag I, Batash D, Keidar R, Barm S, Berkovitch M (2003) Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: A pilot study. Pediatrics 112:354-358
5. Ohlsson A, Walia R, Shah S (2005) Ibuprofen for the treatment of patent ductus arterious in preterm and/or low birth weight. Cochrane Database Syst Rev 4:CD003481
6. Hariprasad P, Sundarrajan V, Srimathy G, Suthagar B, Ramadevi BS (2002) Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr 39:99-100
7. Chotigeat U, Jirapapa K, Layangkool T (2003) A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 86:S563-569
8. Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H (2004) Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr 93:999-1001
9. Simeoni U, Matis J, Messer J (1996) Clinical implications of renal immaturity in tiny, premature infants. In: Cataldi L, Fanos V, Simeoni U (eds) Neonatal nephrology in progress. Agora, Lecce, pp 129-140
10. Van Overmeire B, Touw D, Schepens P, Kearns GL, van den Anker JN (2001) Ibuprofen in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 70:336-343
11. Sharma PK, Garg SK, Narang A (2003) Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 43:968-973
12. Akima S, Kent A, Reynolds GJ, Gallagher M, Falk MC (2004) Indomethacin and renal impairment in neonates. Pediatr Nephrol 19:490-493
13. Thomas RL, Parker KC, Van Overmeire B, Aranda JV (2005) A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 164:135-140
14. Murray MD, Brater DC (1997) Effects of NSAIDs on the kidney. Prog Drug Res 49:155-171
15. Moghal NE, Hegde S, Eastham KM (2004) Ibuprofen and acute renal failure in a toddler. Arch Dis Child 89:276-277
16. Lesko SM, Mitchell AA (1999) The safety of and ibuprofen among children younger than two years old. Pediatrics 104:e39
17. Kelly MT, Walson PD, Edge JH, Cox S, Mortensen ME (1992) Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther 52:181-189
18. Aranda JV, Thomas R (2006) Systemic review: I.v. ibuprofen in preterm infants. Semin Perinatol 30:114-120